Dr. Maniatis is Professor of Molecular and Cellular Biology at Harvard University. He has also held faculty positions at the Cold Spring Harbor Laboratory and the California Institute of Technology. He was a pioneer in the development of gene cloning technology, and he has published extensively in the field of eukaryotic gene regulation. Dr Maniatis is a member of the National Academy of Sciences, and has received numerous awards for his research contributions, including the Eli Lilly Research Award in Microbiology and Immunology, and the Richard Lounsbery Award for Biology and Medicine from the U.S. and French National Academies of Science. He is a co-founder of Genetics Institute, where he chaired the Science Advisory Board and served on the Board of Directors for over 17 years. During this time the company gained FDA approval for several protein-based drugs, including EPO, Factor VIII and Factor IX, as well as bone morphogenic proteins. He was also a co-founder of ProScript Inc., which discovered the drug Velcade, the leading product of Millennium Pharmaceuticals. He is also a co-founder, and member of the Board of Directors and SAB of Acceleron, and a member of the SAB of Sirtris.

TCG Board Representation: Constellation Pharmaceuticals